What ImmuCell Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 8 |
| Sells | 0 | 0 |
| Total trades | 0 | 10 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 10 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Olivier | President and CEO | Jun 18 | Open-market buy · P | +8,000 | $9.50 | +$76K | 17,785 |
| Brigham Michael F | Director | Mar 20 | Withheld — tax / exercise cost · F | −24,052 | $6.07 | −$146K | 205,700 |
| Brigham Michael F | Director | Mar 20 | Exercise / conversion · M | +25,000 | $5.84 | +$146K | 229,752 |
| te Boekhorst Paul Francis Olivier | President and CEO | Dec 04 | Open-market buy · P | +2,432 | $5.50 | +$13.4K | 9,738 |
| te Boekhorst Paul Francis Olivier | President and CEO | Dec 03 | Open-market buy · P | +3,521 | $5.04 | +$17.7K | 9,785 |
| te Boekhorst Paul Francis Olivier | President and CEO | Dec 03 | Open-market buy · P | +2,556 | $5.00 | +$12.8K | 6,264 |
| te Boekhorst Paul Francis Olivier | President and CEO | Dec 03 | Open-market buy · P | +3,598 | $5.05 | +$18.2K | 7,306 |
| te Boekhorst Paul Francis Olivier | President and CEO | Dec 02 | Open-market buy · P | +3,708 | $4.87 | +$18.1K | 3,708 |
| Tomsche David Scott | Director | Nov 25 | Open-market buy · P | +1,633 | $4.77 | +$7.78K | 4,740 |
| Tomsche David Scott | Director | Nov 25 | Open-market buy · P | +1,633 | $4.76 | +$7.77K | 52,720 |
| Gathagan Bryan K. | Director | Jun 12 | Open-market buy · P | +1,000 | $6.32 | +$6.32K | 1,000 |
| Basse Gloria F | Director | Jun 11 | Exercise / conversion · M | +3,530 | $4.81 | +$17K | 3,530 |
| Tomsche David Scott | Director | Aug 28 | Disposition to Issuer · D | +2,186 | $3.55 | +$7.76K | 131,797 |
| Tomsche David Scott | Director | Aug 23 | Disposition to Issuer · D | +6,005 | $3.55 | +$21.3K | 129,611 |
| Tomsche David Scott | Director | Aug 22 | Disposition to Issuer · D | +10,000 | $3.55 | +$35.5K | 123,606 |
| Tomsche David Scott | Director | Aug 19 | Disposition to Issuer · D | +3,172 | $3.67 | +$11.6K | 113,606 |
| Tomsche David Scott | Director | Aug 16 | Disposition to Issuer · D | +4,811 | $3.72 | +$17.9K | 110,434 |
| Tomsche David Scott | Director | Aug 15 | Disposition to Issuer · D | +2,017 | $3.57 | +$7.19K | 105,623 |
| Tomsche David Scott | Director | Sep 06 | Disposition to Issuer · D | +3,100 | $4.75 | +$14.7K | 103,606 |
| Tomsche David Scott | Director | Mar 14 | Disposition to Issuer · D | +100 | $5.44 | +$544 | 100,506 |
Loading...
